Gabapentin and Basophil count increased - a phase IV clinical study of FDA data

Summary:

Basophil count increased is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are female, 60+ old, also take Kisqali, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Basophil count increased when taking Gabapentin. It is created by eHealthMe based on reports of 313,421 people who have side effects when taking Gabapentin from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.

What is Basophil count increased?

Basophil count increased is found to be associated with 171 drugs and 269 conditions by eHealthMe. Check the latest studies of Basophil count increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

313,421 people reported to have side effects when taking Gabapentin.
Among them, 23 people (0.01%) have Basophil count increased.

Could Gabapentin cause Basophil count increased?

Among these 23 people:

What is the gender of people who have Basophil count increased when taking Gabapentin? *

female: 63.16 %
male: 36.84 %

What is the age of people who have Basophil count increased when taking Gabapentin? *

What are other drugs people take besides Gabapentin? *

What are other side effects people have besides Basophil count increased? *

Red Cell Distribution Width Increased: 15 people, 65.22%
Red Blood Cell Count Decreased: 14 people, 60.87%
Monocyte Count Increased: 13 people, 56.52%
Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 12 people, 52.17%
Haematocrit Decreased: 12 people, 52.17%
Lymphocyte Count Increased: 10 people, 43.48%
Haemoglobin Decreased: 10 people, 43.48%
Mean Cell Haemoglobin Increased (more than normal haemoglobin per red blood cell in a sample of blood): 10 people, 43.48%
High Blood Pressure: 9 people, 39.13%
Blood Glucose Increased: 8 people, 34.78%

What are the existing conditions these people have? *

Bone Disorder: 5 people, 21.74%
Breast Cancer Metastatic: 5 people, 21.74%
Muscle Spasms (muscle contraction): 4 people, 17.39%
Stress And Anxiety: 4 people, 17.39%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 17.39%
Nausea (feeling of having an urge to vomit): 4 people, 17.39%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 13.04%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 13.04%
Visual Impairment: 2 people, 8.70%
Back Pain: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and have Basophil count increased?

- Check whether Basophil count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gabapentin:

Gabapentin (322,987 reports)

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Basophil count increased:

Basophil count increased (171 drugs)

Browse all the conditions that are associated with Basophil count increased:

Basophil count increased (269 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.